Thursday, 28 July 2016

Agreement between NRDC and CCRAS

The National Research Development Corporation (NRDC), signed a Memorandum of Association (MoA) with Central Council for Research in Ayurvedic Sciences (CCRAS) on 03.03.2015 for licensing of the technologies developed at the research council to entrepreneurs /companies for commercial exploitation. The benefits that are likely to accrue from the MoA are the following: The Ayurvedic formulations and products
manufactured by the licensee companies are used by the common people for treatment/management of various diseases.

·                     The licensing of the technologies to companies is a source of revenue in terms of lump-sum fee and royalty, which is shared between NRDC and CCRAS.

NRDC has licensed an Anti-Diabetic Ayurvedic formulation for management of Diabetes, viz. ‘AYUSH-82’, developed by CCRAS and assigned to NRDC in February, 2016 to five companies / firms in India till date. The details of these during the last three years and the current year, State-wise and company-wise are as follows:

S. No.
Name of Company
Date of Signing of Agreement
    Financial Year 2016-17
           State - Uttarakhand
M/s Chaturbhuj Pharmaceutical Co.
SIDCUL  Industrial Area, Haridwar
            State  - Himachal Pradesh
Altis Life Sciences, Baddi
      Financial Year 2015-16
            State - Uttarakhand
M/s LA Grande Herbs & Pharma Ltd.
SIDCUL  Industrial Area, Haridwar
            State - Delhi
M/s Kudos Laboratories India Ltd. New Delhi
M/s Dabur India Ltd,
Asaf Ali Road, New Delhi
     Financial Year 2014-15

 NIL, as the technology was assigned to NRDC in Feb 2016

      Financial Year 2013-14

NIL, as the technology was assigned to NRDC in Feb 2016

This was stated by Union Minister for Science & Technology and Earth Sciences, Dr. Harsh Vardhan in a written reply to a Question in Lok Sabha on 27th July, 2016.

No comments:

Post a Comment